JANE STREET GROUP, LLC - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 74366E902. A total of 4 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$690,500
-78.2%
25,000
-81.8%
0.00%
-100.0%
Q1 2023$3,160,200
+1665.5%
137,400
+508.0%
0.00%
Q2 2022$179,00022,6000.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 300,000$5,316,0000.32%
GROUP ONE TRADING, L.P. 8,500$151,0000.00%
SIMPLEX TRADING, LLC 1,400$65,0000.00%
JPMORGAN CHASE & CO 10,000$177,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders